Starting this week, the t:connect mobile app will become the Tandem t:slim mobile app and get a new app icon. These changes will appear after updating to version 2.9 of the app.
Tandem Diabetes Care’s symposium held during the 2022 ISPAD conference in Abu Dhabi (UAE) highlights the pediatric glycemic outcomes of the t:slim X2 insulin pump with Control-IQ technology. Dr. Marc Breton revealed the outcomes of the PEDAP randomized clinical trial in children ages 2-5. Dr. Amelie Poidvin reviewed the sustained glycemic control after 2 years of the school-aged FreeLife Kids cohort. And Dr. Laurel Messer reviewed the results of Control-IQ in the adolescent population.